As of 2025-12-26, the Intrinsic Value of Cardinal Health Inc (CAH) is 227.94 USD. This CAH valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 207.54 USD, the upside of Cardinal Health Inc is 9.80%.
The range of the Intrinsic Value is 161.02 - 392.85 USD
Based on its market price of 207.54 USD and our intrinsic valuation, Cardinal Health Inc (CAH) is undervalued by 9.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 161.02 - 392.85 | 227.94 | 9.8% |
| DCF (Growth 10y) | 204.76 - 467.91 | 281.14 | 35.5% |
| DCF (EBITDA 5y) | 94.86 - 158.41 | 126.86 | -38.9% |
| DCF (EBITDA 10y) | 136.63 - 212.41 | 173.49 | -16.4% |
| Fair Value | 167.82 - 167.82 | 167.82 | -19.14% |
| P/E | 66.97 - 147.28 | 113.83 | -45.2% |
| EV/EBITDA | 69.11 - 179.51 | 128.76 | -38.0% |
| EPV | 102.48 - 136.38 | 119.43 | -42.5% |
| DDM - Stable | 71.06 - 216.28 | 143.67 | -30.8% |
| DDM - Multi | 103.62 - 237.75 | 143.50 | -30.9% |
| Market Cap (mil) | 49,311.50 |
| Beta | 0.39 |
| Outstanding shares (mil) | 237.60 |
| Enterprise Value (mil) | 53,750.50 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.70% |
| Cost of Debt | 4.52% |
| WACC | 6.14% |